RISK-BASED APPROACHES IN GLOBAL REGULATORY SUBMISSIONS FOR RARE DISEASES. Ind-Am. J Pharm. Bio. Sci. 2023;21(3):10-20. Accessed April 17, 2026. https://iajpb.org/index.php/iajpb/article/view/172